Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

38.95
-0.1500-0.38%
Volume:76.27K
Turnover:2.97M
Market Cap:215.39M
PE:- -
High:39.35
Open:39.32
Low:38.45
Close:39.10
52wk High:42.63
52wk Low:13.60
Shares:5.53M
Float Shares:5.53M
Volume Ratio:2.89
T/O Rate:1.38%
Dividend:17.77
Dividend Rate:45.61%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Walvax Biotechnology's Subsidiary Secures Regulatory Approval for COVID-19 mRNA Vaccine

Stock News
·
Sep 10

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live
·
Sep 09

Structure weakness ‘disconnected’ from underlying data, says Jefferies

TIPRANKS
·
Sep 09

Moderately bullish activity in Moderna with shares down 1.79%

TIPRANKS
·
Sep 09

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

The Second Act of Biotech

TIPRANKS
·
Sep 07

Hualan Vaccine's Novel Influenza mRNA Vaccine Clears Clinical Trial Hurdle, No Domestic Competitors Yet

Stock News
·
Sep 07

AI Integration Becomes Essential for Biopharma's Future, Says Henlius CEO

Deep News
·
Sep 05

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
Sep 05

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

Alphamab Oncology Reduces Float with Fresh Share Buyback Valued at HK$492,430

Deep News
·
Sep 04

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Moderna Chief Legal Officer Shannon Thyme Klinger Disposes of USD 485,271.45 in Common Shares

Reuters
·
Sep 04

Cboe data shows mixed options sentiment in Moderna with shares down 3.87%

TIPRANKS
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating

Dow Jones
·
Sep 03

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

MT Newswires Live
·
Sep 03

Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial

Reuters
·
Sep 03

Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Due 2032

Reuters
·
Sep 02

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
Sep 02